Previous 10 | Next 10 |
Second Sight Medical Products, Inc. (NASDAQ:EYES) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Lisa Wilson - Investor Relations Will McGuire - Chief Executive Officer John Blake - Chief Financial Officer Conference Call Participants Am...
Second Sight (NASDAQ: EYES ): Q2 Non-GAAP EPS of -$0.06 in-line; GAAP EPS of -$0.07 in-line. More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
-- R&D and Clinical Programs for Orion ® Visual Cortical Prosthesis System on Track -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that...
Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second quarter of 2019 on Tuesday, August 6, 20...
Second Sight Medical Products (NASDAQ: EYES ) jumps 22% after hours in response to positive data on six blind patients receiving its Orion Visual Cortical Prosthesis System. The results were presented at the World Society for Stereotactic and Functional Neurosurgery Annual Meet...
Study Investigators from UCLA and Baylor Provide Latest Study Update at the World Society for Stereotactic and Functional Neurosurgery Annual Meeting Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufactu...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced today th...
Second Sight Medical Products, Inc. (EYES) Q1 2019 Results Earnings Conference Call May 15, 2019, 04:30 PM ET Company Participants Lisa Wilson - Investor Relations Jonathan McGuire - CEO, President John Blake - CFO & Corporate Secretary Conference Call Participants Same...
Second Sight Medical (NASDAQ: EYES ) Q1 highlights : More news on: Second Sight Medical Products, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Second Sight (NASDAQ: EYES ): Q1 Non-GAAP EPS of -$0.07 misses by $0.01 ; GAAP EPS of -$0.10 misses by $0.03 . More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...